lamotrigine
Generic: lamotrigine
Labeler: northstar rx llcDrug Facts
Product Profile
Brand Name
lamotrigine
Generic Name
lamotrigine
Labeler
northstar rx llc
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
lamotrigine 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
16714-626
Product ID
16714-626_9c4867cc-d291-bb7a-2942-69dab9cede75
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202383
Listing Expiration
2026-12-31
Marketing Start
2017-06-20
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
16714626
Hyphenated Format
16714-626
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lamotrigine (source: ndc)
Generic Name
lamotrigine (source: ndc)
Application Number
ANDA202383 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-626-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9c4867cc-d291-bb7a-2942-69dab9cede75", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["850087", "850091", "900156", "900164", "1098608", "1146690"], "spl_set_id": ["9ab07d6b-ae4a-a310-5572-b266676cd29e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["NorthStar Rx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-626-01)", "package_ndc": "16714-626-01", "marketing_start_date": "20170620"}], "brand_name": "Lamotrigine", "product_id": "16714-626_9c4867cc-d291-bb7a-2942-69dab9cede75", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "16714-626", "generic_name": "Lamotrigine", "labeler_name": "NorthStar Rx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "200 mg/1"}], "application_number": "ANDA202383", "marketing_category": "ANDA", "marketing_start_date": "20170620", "listing_expiration_date": "20261231"}